Roquette Sues to Protect Mannitol Patent

Email Article
 
Print

06 June 2007

In its continuing effort to protect its product innovation and investment in research and development, Roquette Fréres filed suit for patent infringement against SPI Pharma, Inc. and Drytec Ltd., in the US District Court for the district of Delaware.

The complaint alleges that the defendants' spray-dried mannitol products, including MANNOGEM™ EZ spray dried mannitol infringe Roquette's patented technology.

The Roquette US Patent No.5,573,777, filed in 1993, protects a new physical form of mannitol that maximizes performance as a directly compressible excipient in the pharmaceutical industry.

Roquette's mannitol (PEARLITOL®) offers excellent tableting characteristics as well as the advantage of being non-cariogenic and non-hygroscopic. Its uniquely controlled particle size distribution also allows good flow and dissolution properties while minimizing dust and preventing explosions during production or packaging.


Post to:
Delicious  
Digg  
reddit  
Facebook  
StumbleUpon  


Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

The website for the pharmaceutical industry